Bei Akademie registrieren
Recordati, IT0003828271

Recordati stock at EUR 52.43 ahead of the Xetra open: pharma group

Published on 10/22/2026 at 08:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Recordati develops and commercializes medicines for common and rare diseases. At Lang & Schwarz the stock trades pre-market at EUR 52.43 on October 22, 2026.

Business model and market context

  • Recordati develops and commercializes medicines for common and rare diseases.
  • The Italian pharmaceutical group is covered by the FTSE MIB market context.
  • Recordati stock trades pre-market at EUR 52.43 at 8:06 a.m. CEST at Lang & Schwarz on October 22, 2026.
Isometrische 3D-Illustration der Pharma-Wertschöpfungskette von Labor bis Vertrieb
Recordati S.p.A. (IT0003828271) durchläuft eine Wertschöpfungskette, dargestellt als isometrisches 3D-Diagramm der Pharma-Produktion, Illustration mit AI erstellt.

Recordati develops and commercializes medicines for people with common and rare diseases, according to the company's investor-relations page. Recordati stock trades pre-market at EUR 52.43 at 8:06 a.m. CEST at Lang & Schwarz on October 22, 2026.

Ahead of the Xetra open

The bid was EUR 52.10 and the ask EUR 52.75, a spread of 1.24 percent. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Recordati stock.

The group and its market

Recordati earns revenue by developing and commercializing medicines for common and rare diseases. The company is listed on the Italian stock exchange. Market context: Market report FTSE MIB.

More news and analysis on Recordati stock

Disclaimer...
en | IT0003828271 | RECORDATI | boerse | 70390487 | bgmi